Study of patients with ITP estimating the proportion administering Romiplostim correctly after receiving home administration training
Study Details
Cross-sectional study, observation made by healthcare professionals of subjects or caregivers, administering romiplostim at their first standard-of-care visit 4 weeks after training with the home administration training pack. Further observations can also be recorded in the study if made within 16 weeks of enrolment. Data will be collected from the subjects’ dose diary at their first standard of care visit to ensure there were no problems with administration while not at the clinic.
Protocol Summary
Successful self administration of romiplostim
Timeframe: First Standard of Care visit post Home Administration Training (range 2-8 weeks)
successful reconstitution of romiplostim
Timeframe: First standard of care visit post Home Administration Training (range 2-8 weeks). Follow up visits (up to 16 weeks post enrolment)
Accuracy in administering the prescribed dose of romiplostim
Timeframe: First standard of care visit post Home Administration Training (range 2-8 weeks). Follow up visits (up to 16 weeks post enrolment)
Injects romiplostim
Timeframe: First standard of care visit post Home Administration Training (range 2-8 weeks). Follow up visits (up to 16 weeks post enrolment)
Administers romiplostim
Timeframe: Follow up visits (up to 16 weeks post enrolment)